Table 4.

Healthcare resource use over 12 months

Result parameter	Mirabegron 50 mg	Fesoterodine 4/8 mg	Oxybutynin ER 5 mg	Oxybutynin IR 5 mg	Solifenacin 5/10 mg	Tolterodine ER 4 mg	Tolterodine IR 4 mg	Trospium ER 60 mg	Trospium IR 40 mg	Darifenacin 7.5 mg	Flavoxate 600 mg
GP visits	115	119	121	122	119	120	120	120	120	121	123
Specialist visits	173	178	181	183	178	180	180	180	180	182	185
Surgical operations	0.0042	0.0051	0.0055	0.0058	0.0050	0.0053	0.0053	0.0054	0.0054	0.0056	0.0060
Total pad use	71,807	76,853	79,798	82,194	76,531	78,274	78,274	78,932	78,932	80,414	84,602
On treatment	40,123	35,918	33,464	31,467	36,187	34,734	34,734	34,186	34,186	32,950	29,461
Off treatment	31,684	40,934	46,334	50,727	40,334	43,540	43,540	44,747	44,747	47,464	55,142

All doses reported are the total dose per day

ER extended release, GP general practitioner, IR immediate release